StreetInsider.com News Articles

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Fri, 27 Feb 2026 08:00:00 -0500

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th.

Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Fri, 27 Feb 2026 08:00:00 -0500

Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Fri, 27 Feb 2026 08:00:00 -0500

Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Fri, 27 Feb 2026 08:00:00 -0500

Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing

OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance

Thu, 26 Feb 2026 16:17:13 -0500

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $148.5 million versus the consensus estimate of $139.76 million.

GUIDANCE:

OPKO Health sees Q1 2026 revenue of $125-140 million, versus the consensus of $130.8 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance

Thu, 26 Feb 2026 16:17:13 -0500

GUIDANCE:

OPKO Health sees Q1 2026 revenue of $125-140 million, versus the consensus of $130.8 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

Form 10-K OPKO HEALTH, INC. For: Dec 31

Thu, 26 Feb 2026 16:16:00 -0500

http://archive.fast-edgar.com/20260226/AU2VA22CZZ2RKJZU22ZI2ZYSGQLFZZ22Z286

Filed on: February 26, 2026

Form 10-K OPKO HEALTH, INC. For: Dec 31

Thu, 26 Feb 2026 16:16:00 -0500

http://archive.fast-edgar.com/20260226/AU2VA22CZZ2RKJZU22ZI2ZYSGQLFZZ22Z286

Filed on: February 26, 2026

Form 8-K OPKO HEALTH, INC. For: Feb 26

Thu, 26 Feb 2026 16:10:00 -0500

si-local-file:///var/storage/secattach/20260226/26070666.html

Form 8-K OPKO HEALTH, INC. For: Feb 26

Thu, 26 Feb 2026 16:10:00 -0500

si-local-file:///var/storage/secattach/20260226/26070666.html

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

Thu, 26 Feb 2026 16:05:00 -0500

MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026.